Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity

Whakaahuatanga Poto:

Ingoa matū: Lasofoxifene Tartrate

CAS: 190791-29-8

Te ahua: Ma ki te Paura-White

Maamaa Chiral: ≥99.0%Maamaa: ≥98.0% (HPLC)

I roto i te maimoatanga o Postmenopausal Osteoporosis

API Kounga Teitei, Hanganga Tauhokohoko

Inquiry: alvin@ruifuchem.com

Tukuna he imeera ki a matou

Taipitopito Hua

Hua e Pa ana

Tohu Hua

Whakaahuatanga:

Ko te Kaihanga Kaihanga me te Maama me te Kounga Pumau
Ingoa matū: Lasofoxifene Tartrate
CAS: 190791-29-8
Lasofoxifene Tartrate (CAS: 190791-29-8) i roto i te maimoatanga o Postmenopausal Osteoporosis

Ngā Āhuatanga matū:

Ingoa matū	Lasofoxifene Tartrate
Nga kupu taurite	(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia
Tau CAS	190791-29-8
Tau CAT	RF-API20
Tūnga Taonga	Kei roto i nga taonga, ka eke ki te rau kirokaramu
Tātai rāpoi	C28H31NO2.ClH
Taumaha rāpoi	450.019
Waitohu	Ruifu Chemical

Whakatakotoranga:

Tūemi	Whakatakotoranga
Te ahua	Ma ki te Paura-White
makuku (KF)	≤0.50%
Nga Korewa Taamaha	≤20ppm
Chiral Pure	≥99.0%
Te Maama / Tikanga Tatauria	≥98.0% (HPLC)
Ngaronga i te whakamaroke	≤0.50%
Te toenga i runga i te mura	≤0.50%
Paerewa Whakamatau	Hainamana Pharmacopoeia (CP);Paerewa hinonga
Whakamahinga	Mahinga Rongoa Hohe (API);Osteoporosis i muri i te menopause

Mōkī me te Rokiroki:

Mōkī: Pounamu, Peeke konumohe konumohe, Pahu Kaata, 25kg / Drum, kia rite ranei ki te hiahia a te kaihoko.

Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Whakaorangia mai i te marama, te makuku me te mate kino.

Painga:

FAQ:

Taupānga:

Ko Shanghai Ruifu Chemical Co., Ltd. te kaihanga matua me te kaiwhakarato o Lasofoxifene Tartrate (CAS: 190791-29-8) me te kounga teitei.
Ko te Lasofoxifene Tartrate he tuatoru-whakatupuranga, kore-steroidal selective estrogen receptor modulator (SERM).Ka herea maataki ki te ERalpha tangata me te uara IC50 o te 1.5 nM me te aukati i te mate wheua i roto i nga kiore ovariectomized.I roto i nga rangahau haumanu mo te osteoporosis postmenopausal, ko te 0.5 mg / ra lasofoxifene i hono ki te whakaheke i nga tupono o nga pakaru kore-vertebral me te vertebral, te mate pukupuku ER-positive, te mate ngakau coronary, me te whiu engari he nui ake te mate o nga kaupapa thromboembolic vena.Kua whakaatuhia hoki te Lasofoxifene ki te mahi hei agonist inverse i te CB2 cannabinoid receptor, e tohu ana i tona kaha ki te whakahoki ano hei rongoa mo nga tohu kei a CB2 te whaainga.